Imaging IT Radiopharmaceuticals Workshop 
Imaging Technology
JUNE 15, 2023
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Lancet Oncology 2023; 24(3): e133-e143.
Imaging Technology
MAY 17, 2024
or with virtual access to livestreams of all scientific and educational sessions. Additionally, for those attending in person, more than 170 exhibitors will showcase state-of-the-art technologies for cancer care in the ASTRO Exhibit Hall.
Imaging Technology
NOVEMBER 2, 2023
To develop the AI models, GE HealthCare and VUMC retrospectively analyzed and correlated the immunotherapy treatment response of thousands of VUMC cancer patients, with their deidentified demographic, genomic, tumor, cellular, proteomic, and imaging data. Lancet Oncology 2023; 24(3): e133-e143.
Expert insights. Personalized for you.
89 
Let's personalize your content